Interestingly, a study conducted by Pei et al. compared the diagnostic performance of different novel AKI biomarkers, namely, CysC, NGAL, kidney injury molecule-1, and fibroblast growth factor-23 in a Chinese cohort with diagnosed sepsis. The gene discussed is LCN2; the disease is Sepsis.